156 related articles for article (PubMed ID: 27345334)
21. A new Mycobacterium species causing diffuse lepromatous leprosy.
Han XY; Seo YH; Sizer KC; Schoberle T; May GS; Spencer JS; Li W; Nair RG
Am J Clin Pathol; 2008 Dec; 130(6):856-64. PubMed ID: 19019760
[TBL] [Abstract][Full Text] [Related]
22. Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
Li X; Li G; Yang J; Jin G; Shao Y; Li Y; Wei P; Zhang L
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293307
[TBL] [Abstract][Full Text] [Related]
23. Mycobacterium lepromatosis Infections in Nuevo León, Mexico.
Vera-Cabrera L; Escalante-Fuentes W; Ocampo-Garza SS; Ocampo-Candiani J; Molina-Torres CA; Avanzi C; Benjak A; Busso P; Singh P; Cole ST
J Clin Microbiol; 2015 Jun; 53(6):1945-6. PubMed ID: 25809978
[TBL] [Abstract][Full Text] [Related]
24. Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis.
Collin SM; Lima A; Heringer S; Sanders V; Pessotti HA; Deps P
Emerg Infect Dis; 2023 Jul; 29(7):1376-1385. PubMed ID: 37347507
[TBL] [Abstract][Full Text] [Related]
25. What is the evidence that the putative Mycobacterium lepromatosis species causes diffuse lepromatous leprosy?
Gillis TP; Scollard DM; Lockwood DN
Lepr Rev; 2011 Sep; 82(3):205-9. PubMed ID: 22125927
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas.
Virk A; Pritt B; Patel R; Uhl JR; Bezalel SA; Gibson LE; Stryjewska BM; Peters MS
Emerg Infect Dis; 2017 Nov; 23(11):1864-1866. PubMed ID: 29048278
[TBL] [Abstract][Full Text] [Related]
27. Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis.
Han XY; Sizer KC; Thompson EJ; Kabanja J; Li J; Hu P; Gómez-Valero L; Silva FJ
J Bacteriol; 2009 Oct; 191(19):6067-74. PubMed ID: 19633074
[TBL] [Abstract][Full Text] [Related]
28. Genomic characterization of Mycobacterium lepromatosis from ENL patients from India.
Singh I; Pathak VK; Lavania M; Ahuja M; Sharma R; Narang T; Jain S; Turankar RP; Dogra S; Sengupta U
Infect Genet Evol; 2023 Dec; 116():105537. PubMed ID: 38056703
[TBL] [Abstract][Full Text] [Related]
29. Clinical, histopathological, and molecular characterization of leprosy in an endemic area of the colombian caribbean.
Fragozo-Ramos MC; Cano-Pérez E; Sierra-Merlano RM; Camacho-Chaljub F; Gómez-Camargo D
Int J Mycobacteriol; 2021; 10(2):155-161. PubMed ID: 34558467
[TBL] [Abstract][Full Text] [Related]
30. Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India.
Singh SK; Kumar A; Nath G; Singh TB; Mishra MN
Indian J Dermatol Venereol Leprol; 2018; 84(3):275-279. PubMed ID: 29536982
[TBL] [Abstract][Full Text] [Related]
31. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
Nakata N; Kai M; Makino M
Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
[TBL] [Abstract][Full Text] [Related]
32. A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampin.
Zhang L; Namisato M; Matsuoka M
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):468-72. PubMed ID: 15755201
[TBL] [Abstract][Full Text] [Related]
33.
Deps P; Collin SM
Front Microbiol; 2021; 12():698588. PubMed ID: 34566911
[No Abstract] [Full Text] [Related]
34. Severe leprosy reactions due to Mycobacterium lepromatosis.
Han XY; Jessurun J
Am J Med Sci; 2013 Jan; 345(1):65-9. PubMed ID: 23111393
[TBL] [Abstract][Full Text] [Related]
35. Mycobacterium lepromatosis genome exhibits unusually high CpG dinucleotide content and selection is key force in shaping codon usage.
Munjal A; Khandia R; Shende KK; Das J
Infect Genet Evol; 2020 Oct; 84():104399. PubMed ID: 32512206
[TBL] [Abstract][Full Text] [Related]
36. Detection of
Ahuja M; Lavania M; Singh I; Turankar RP; Chhabra S; Narang T; Dogra S; Sengupta U
Infect Drug Resist; 2018; 11():1677-1683. PubMed ID: 30349325
[TBL] [Abstract][Full Text] [Related]
37. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
38. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
39. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
40. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.
Hasanoor Reja AH; Biswas N; Biswas S; Lavania M; Chaitanya VS; Banerjee S; Maha Patra PS; Gupta UD; Patra PK; Sengupta U; Bhattacharya B
Indian J Dermatol Venereol Leprol; 2015; 81(2):155-61. PubMed ID: 25751332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
